Understanding Duralast
Duralast 30mg is a pharmaceutical preparation containing dapoxetine hydrochloride, manufactured by Sun Pharmaceuticals Industries Limited for in-vitro research applications. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that demonstrates rapid onset pharmacokinetics and short elimination half-life properties in preclinical models. Research teams at Stroid UK Shop investigate this compound’s unique pharmacological profile, particularly its distinctive serotonergic receptor binding characteristics and transport protein interactions. The compound’s molecular structure allows researchers to examine selective inhibition pathways in controlled laboratory environments, providing valuable insights into neurotransmitter modulation mechanisms.
Laboratory Applications
Scientists examine Duralast 30mg tablets to investigate serotonin transporter binding affinities and competitive inhibition kinetics. The compound serves as a research tool for studying rapid-acting SSRI mechanisms, enabling researchers to analyse onset profiles and clearance patterns in experimental models. Laboratory protocols utilise this preparation to examine dose-response relationships and receptor occupancy dynamics. Research teams studying erection drugs and dapoxetine compounds frequently employ this pharmaceutical grade material for comparative pharmacological studies. The standardised dosage format facilitates consistent experimental conditions across multiple research protocols, supporting reproducible scientific investigations into serotonergic pathway modulation.
Technical Specifications
| Active Ingredient | Dapoxetine Hydrochloride 30mg |
|---|---|
| Manufacturer | Sun Pharmaceuticals Industries Limited |
| Compound Class | Selective Serotonin Reuptake Inhibitor |
| Dosage Form | Film-coated tablets |
| CAS Number | 119356-77-3 |
| Molecular Formula | C₂₁H₂₃NO·HCl |
| Storage Requirements | Room temperature, dry environment |
Research laboratories studying neuropharmacological compounds often integrate investigations with related categories including selective androgen receptor modulators and peptide research compounds to examine comprehensive receptor interaction profiles. This pharmaceutical preparation enables researchers to conduct controlled studies examining serotonergic system modulation alongside other neurotransmitter pathways.
Research Compliance
Duralast 30mg tablets from Sun Pharmaceuticals Industries are supplied exclusively for legitimate scientific research purposes in properly equipped laboratory facilities. This product is intended solely for in-vitro research applications and must not be used for human consumption, therapeutic treatment, or any purpose outside controlled scientific investigation. Researchers must comply with all applicable laboratory safety protocols and institutional guidelines when handling this compound.
